Nigel H Russell

Nigel H Russell

UNVERIFIED PROFILE

Are you Nigel H Russell?   Register this Author

Register author
Nigel H Russell

Nigel H Russell

Publications by authors named "Nigel H Russell"

Are you Nigel H Russell?   Register this Author

71Publications

1752Reads

5Profile Views

DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia.

Br J Haematol 2019 Jul 5;186(2):343-347. Epub 2019 Mar 5.

Department of Academic Haematology, School of Medicine, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15823DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617782PMC
July 2019

Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma.

Br J Haematol 2019 Mar 17;184(6):999-1005. Epub 2018 Dec 17.

Department of Haematology, University College London Cancer Institute, London, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.15723
Publisher Site
http://dx.doi.org/10.1111/bjh.15723DOI Listing
March 2019

Targeting FLT3 mutations in AML: review of current knowledge and evidence.

Leukemia 2019 02 16;33(2):299-312. Epub 2019 Jan 16.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41375-018-0357-9
Publisher Site
http://dx.doi.org/10.1038/s41375-018-0357-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365380PMC
February 2019

Genetic biomarkers predict response to dual BCL-2 and MCL-1 targeting in acute myeloid leukaemia cells.

Oncotarget 2018 Dec 28;9(102):37777-37789. Epub 2018 Dec 28.

Clinical Haematology, Nottingham University Hospitals, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26540DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340871PMC
December 2018

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations.

J Clin Oncol 2018 05 30;36(15):1486-1497. Epub 2018 Mar 30.

Sylvie D. Freeman and Naeem Khan, University of Birmingham, Birmingham; Robert K. Hills, Amanda Gilkes, Laura Upton, Ian Thomas, and Alan K. Burnett, Cardiff University; Steve Couzens University Hospital of Wales, Cardiff; Paul Virgo, North Bristol NHS Trust, Bristol; Richard Dillon and David Grimwade, King's College London School of Medicine; James D. Cavenagh, Queen Mary University of London; Asim Khwaja, University College London, London; Gail Jones, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle; Paul Cahalin, Blackpool Teaching Hospital NHS Foundation Trust, Blackpool; Nigel H. Russell, Nottingham University Hospital, Nottingham, United Kingdom; Ove Juul Nielsen, Rigshospitalet, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.3425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959196PMC
May 2018

No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials.

Blood 2018 01 11;131(4):468-471. Epub 2017 Dec 11.

Department of Haematology, University College London Cancer Institute, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-08-802157DOI Listing
January 2018

Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia.

Blood 2016 07 6;128(3):449-52. Epub 2016 Jun 6.

Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-04-712091DOI Listing
July 2016

Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial.

J Clin Oncol 2013 Sep 12;31(27):3360-8. Epub 2013 Aug 12.

Alan K. Burnett and Robert K. Hills, Cardiff University School of Medicine, Cardiff; Nigel H. Russell, Nottingham University Hospital National Health Service Trust, Nottingham; Ann E. Hunter, Leicester Royal Infirmary, Leicester; John Yin, Manchester Royal Infirmary, Manchester Brenda E.S. Gibson, Royal Hospital for Sick Children, Yorkhill, Glasgow; Keith Wheatley, Cancer Research UK Clinical Trials Unit, University of Birmingham; and Donald Milligan, Birmingham Heartlands Hospital, Birmingham, United Kingdom; and Lars Kjeldsen, Rigshopitalet, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.4874DOI Listing
September 2013

Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival.

Blood 2013 Aug 9;122(8):1384-94. Epub 2013 Jul 9.

Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-04-496596DOI Listing
August 2013

Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia.

J Clin Oncol 2012 Nov 30;30(32):3924-31. Epub 2012 Jul 30.

FMedSci, Department of Haematology, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.42.2964DOI Listing
November 2012

Improving outcomes for elderly patients with AML.

Authors:
Nigel H Russell

Lancet Oncol 2012 Nov;13(11):1065-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70450-3DOI Listing
November 2012

P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA.

BMC Cancer 2011 Jun 16;11:254. Epub 2011 Jun 16.

Department of Academic Haematology, The University of Nottingham, Clinical Sciences Building, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-11-254DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146447PMC
June 2011

Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission.

Ann Hematol 2010 May 30;89(5):505-12. Epub 2009 Oct 30.

Department of Clinical Haematology, Nottingham University Hospitals-City Campus, Nottingham, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-009-0853-0
Publisher Site
http://dx.doi.org/10.1007/s00277-009-0853-0DOI Listing
May 2010

Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.

Lancet Oncol 2010 Apr 30;11(4):331-8. Epub 2010 Jan 30.

Hematology and Stem Cell Transplantation, Asklepios Hospital St Georg, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(09)70352-3DOI Listing
April 2010

FLT3-ITD expression levels and their effect on STAT5 in AML with and without NPM mutations.

Br J Haematol 2009 Dec 22;147(5):653-61. Epub 2009 Sep 22.

Department of Academic Haematology, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2009.07901.xDOI Listing
December 2009

Defining conditioning regimens for BMT--recognition of "regimens of intermediate intensity".

Biol Blood Marrow Transplant 2009 Jul 14;15(7):890-1; author reply 891. Epub 2009 May 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.02.012DOI Listing
July 2009

Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab.

Biol Blood Marrow Transplant 2007 Jun;13(6):724-33

Centre for Clinical Haematology, Nottingham University Hospitals (City Campus), Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387910700189
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2007.02.011DOI Listing
June 2007

The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants.

Biol Blood Marrow Transplant 2007 May 15;13(5):550-9. Epub 2007 Feb 15.

Department of Haematology, Nottingham City Hospital Campus, Nottingham University Hospitals, Nottingham UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2006.12.451DOI Listing
May 2007

HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants.

Blood 2006 Feb 18;107(3):1220-6. Epub 2005 Oct 18.

Anthony Nolan Research Institute, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-08-3121DOI Listing
February 2006

BAT-25 and BAT-26, two mononucleotide microsatellites, are not sensitive markers of microsatellite instability in acute myeloid leukaemia.

Br J Haematol 2004 Jan;124(2):160-5

Division of Haematology, Department of Clinical Laboratory Sciences, University of Nottingham, Clinical Sciences Building, Hucknall Road, Nottingham NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2003.04750.xDOI Listing
January 2004

Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells.

Exp Hematol 2002 May;30(5):495-501

Division of Haematology, School of Clinical Laboratory Sciences, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
May 2002

Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution.

Blood 2002 Apr;99(7):2586-91

Division of Haematology, School of Clinical Laboratory Sciences, University of Nottingham, City Hospital, Hucknall Road, Nottingham NG5 1PB, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.v99.7.2586DOI Listing
April 2002